High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations

Amélie BoichardCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA, USACorrespondence[email protected]

Igor F. TsigelnyCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA;San Diego Supercomputer Center, University of California San Diego, La Jolla, CA, USA;Department of Neurosciences, University of California San Diego, La Jolla, CA, USA;CureMatch Inc., San Diego, CA, USA

Razelle KurzrockCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA

High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations

KONI_A_1284719_Supplemental_Tables1-7.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations

KONI_A_1284719_Supplemental_Tables1-7.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date